The latest research indicates the risks of blood clots from AstraZeneca are extremely small, with data coming out from millions of people around the world who have had the COVID-19 vaccine.
Two studies have come from the University of Edinburgh and were published in academic journal PLOS Medicine. The first by William Whiteley analysed the electronic health records of 46 million adults in England with 21 million being vaccinated from December 2020 to March 2021.
From this data, Dr Whiteley found approximately 0.9-3 people per million were likely to experience extreme side effects.
